Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Accentuates Venclexta Superiority To Imbruvica

Jun 20 2016

• By Brenda Sandburg

Related Content

Roche/AbbVie Move Beyond GDC-0199 Toxicity Issue To Show Results In Tough-To-Treat CLL

Dec 09 2013

Related Companies

AbbVie Inc.

Roche Holding AG

Johnson & Johnson

Abbott

Gilead Sciences, Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

Genentech, Inc.

Pharmacyclics, Inc.

Johnson & Johnson

Johnson & Johnson

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window